BN Business News
Add your company to Business Communicator →

Regulation & law · 23/10/2001Updated: 10/17/2026 · 1 min read

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Detection of Antibodies to Squalene in Serum

Summary

The U.S. Patent and Trademark Office (USPTO) is announcing the availability for licensing of a patent application concerning the detection of antibodies to squalene in serum, with patent application number 09/859,389, filed on May 18, 2001. The patent has been assigned to the U.S. Government, as represented by the Secretary of the Army.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →